GlassScriptPhysician profile
James F Trotter
NPI 1225128903
$15,194.58
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $8,177 · 2021: $2,182 · 2022: $105 · 2023: $2,305 · 2024: $2,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,284 · Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,283.75 |
| Food and Beverage | $248.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $5,000.00 | 2020 | |
| Modernatx, INC. | $4,283.75 | 2023-2024 | |
| Organox LTD | $3,000.00 | 2020 | |
| Gilead Sciences, INC. | $2,241.14 | 2019-2023 | |
| Abbvie INC. | $470.69 | 2020-2024 | Mavyret |
| Mallinckrodt Enterprises LLC | $72.85 | 2019 | |
| Shionogi INC | $44.52 | 2019 | |
| Dova Pharmaceuticals | $33.17 | 2021 | |
| Gi Supply, INC. | $31.61 | 2022 | |
| Optos, INC. | $16.85 | 2021 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Trotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.